Shilanski & Associates’s Braskem BAK Stock Holding History

Shilanski & Associates’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-1,800	Closed	-$420K	–	105
2024 Q4	$420K	Hold	1,800	–	–	0.13%	68
2024 Q3	$368K	Hold	1,800	–	–	0.12%	71
2024 Q2	$352K	Buy	1,800 +127	+8%	+$1.01K	0.12%	70
2024 Q1	$335K	Hold	1,673	–	–	0.12%	74
2023 Q4	$333K	Hold	1,673	–	–	0.13%	72
2023 Q3	$315K	Hold	1,673	–	–	0.13%	79
2023 Q2	$328K	Sell	1,673 -343	-17%	-$3.25K	0.13%	78
2023 Q1	$403K	Sell	2,016 -80	-4%	-$649	0.18%	73
2022 Q4	$488K	Buy	+2,096	New	+$23.3K	0.21%	72
2022 Q3	–	Sell	-2,200	Closed	-$534K	–	149
2022 Q2	$534K	Hold	2,200	–	–	0.25%	70
2022 Q1	$590K	Hold	2,200	–	–	0.25%	71
2021 Q4	$510K	Hold	2,200	–	–	0.22%	72
2021 Q3	$506K	Hold	2,200	–	–	0.24%	71
2021 Q2	$495K	Buy	+2,200	New	+$43.9K	0.23%	69

Other funds holding BAK

OCM

Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return

Kapitalo Investimentos Sao Paulo, Brazil $1.58B AUM 19.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Shilanski & Associates's BAK Position: Q1 2025 in Review

Shilanski & Associates sold out of Braskem (BAK) in Q1 2025, closing a stake of 1,800 shares — an estimated $420K sold.

Shilanski & Associates first reported a position in BAK in Q2 2021 and held it in 14 quarters. The position peaked at $590K in Q1 2022. 58 funds tracked by Wall St. Rank hold BAK as of Q1 2025.

Shilanski & Associates reported no remaining Braskem position as of Q1 2025 after selling out during the quarter.
Shilanski & Associates sold 1,800 Braskem shares in Q1 2025, an estimated $420K.
Shilanski & Associates first reported a position in Braskem in Q2 2021 and held it in 14 quarters.
Shilanski & Associates's Braskem position peaked at $590K in Q1 2022.
58 funds tracked by Wall St. Rank held Braskem as of Q1 2025.

Based on Shilanski & Associates's 13F filing for Q1 2025, filed 25 Apr 2025.